- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 277/64 - Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
Patent holdings for IPC class C07D 277/64
Total number of patents in this class: 469
10-year publication summary
|
48
|
49
|
25
|
38
|
24
|
35
|
29
|
43
|
19
|
13
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4747 |
15 |
| Antabio SAS | 23 |
9 |
| Rutgers, The State University of New Jersey | 1996 |
9 |
| FUJIFILM Corporation | 30808 |
8 |
| The Regents of the University of Michigan | 5063 |
8 |
| Janssen Pharmaceutica N.V. | 3137 |
7 |
| CHDI Foundation, Inc. | 108 |
7 |
| The General Hospital Corporation | 4900 |
6 |
| Avexxin AS | 41 |
6 |
| EyePoint Pharmaceuticals, Inc. | 39 |
6 |
| Lighthouse Pharmaceuticals, Inc. | 11 |
6 |
| Eyepoint, Inc. | 62 |
6 |
| Takeda Pharmaceutical Company Limited | 2709 |
5 |
| Agios Pharmaceuticals, Inc | 233 |
5 |
| Genzyme Corporation | 1383 |
5 |
| Gilead Sciences, Inc. | 2256 |
5 |
| King Faisal University | 936 |
5 |
| National Institutes for Quantum and Radiological Science and Technology | 101 |
5 |
| Sun Pharma Advanced Research Company Ltd. | 186 |
5 |
| Idorsia Pharmaceuticals Ltd. | 332 |
5 |
| Other owners | 336 |